Ezetimibe Versus Alirocumab and Plaque Vulnerability in Patients with Acute Coronary Syndrome Not Achieving LDL-Cholesterol Target with Statin Therapy: The COMBI-LLT-ACS Randomized Trial
- DOI
- 10.3390/jcm15197564
- Published
- 2026-09-29
- Container
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/jcm15197564,
title = {Ezetimibe Versus Alirocumab and Plaque Vulnerability in Patients with Acute Coronary Syndrome Not Achieving LDL-Cholesterol Target with Statin Therapy: The COMBI-LLT-ACS Randomized Trial},
author = {Anna Kovalskaya and Guzel Bikbaeva and Dmitry Duplyakov and Polina Duplyakova and Ekaterina Sukhinina and Ekaterina Savinova},
year = {2026},
journal = {Journal of Clinical Medicine},
doi = {10.3390/jcm15197564},
url = {https://doi.org/10.3390/jcm15197564}
}RIS
TY - JOUR TI - Ezetimibe Versus Alirocumab and Plaque Vulnerability in Patients with Acute Coronary Syndrome Not Achieving LDL-Cholesterol Target with Statin Therapy: The COMBI-LLT-ACS Randomized Trial AU - Anna Kovalskaya AU - Guzel Bikbaeva AU - Dmitry Duplyakov AU - Polina Duplyakova AU - Ekaterina Sukhinina AU - Ekaterina Savinova PY - 2026 JO - Journal of Clinical Medicine DO - 10.3390/jcm15197564 UR - https://doi.org/10.3390/jcm15197564 ER -
APA
Kovalskaya, A., Bikbaeva, G., Duplyakov, D., Duplyakova, P., Sukhinina, E., & Savinova, E. (2026). Ezetimibe Versus Alirocumab and Plaque Vulnerability in Patients with Acute Coronary Syndrome Not Achieving LDL-Cholesterol Target with Statin Therapy: The COMBI-LLT-ACS Randomized Trial. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15197564
Source records
- crossref · retrieved 2026-11-10T09:08:07.324Z